DEMETRA - ADVICE-002-2022

NCT05394779 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
246
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Advice Pharma Group srl